Corporate News Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges Consolidated revenue up year on year by 10.8% to EUR 1,135.4 million Adjusted consolidated EBITDA declines 13.8% to EUR 310.2 million Adjusted consolidated EBITDA margin at 27.3% [...]

This is an abstract of the document. To keep reading, click here and get access to the original version.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Dermapharm Holding SE published this content on 27 March 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 April 2024 09:40:01 UTC.